Swiss database for tracking hard-to-treat infections
Part of Infections clinical trials.
This study builds a Swiss database using lab genetic testing (whole genome sequencing) plus basic patient information to track outbreaks of serious, drug-resistant, and sometimes high-infectious pathogens. Your data could help researchers understand how these germs spread and how to better prevent them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a patient with an infection or colonization (germs found in your body without causing symptoms).
- Your germ must be one of the study-target pathogens (certain drug-resistant bacteria or specific common/serious bacteria and viruses).
- You must have whole genome sequencing (genetic sequencing of the germ) available.
- Basic epidemiologic, demographic, and clinical information must be available for research use.
- You must be willing to sign general research consent (or otherwise agree to use your data).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects and studies lab-detected germs in hospital patients that produce special enzymes making some antibiotics less effective. It helps researchers understand how these resistant germs spread over time in Switzerland.
This study looks at new ways to fight antibiotic-resistant bacteria in people with certain common infections. It may help by testing approaches tailored to the specific germs found in your urine, lungs, or deeper infections.
This study collects health information from adults with bloodstream infections to learn more about how these infections are managed and to find better ways to treat them. If you join, your medical data may be used for research, and you might be invited to join a sub-study about treatments.
This study looks at whether certain bacteria that carry ESBL enzymes are spreading between people. To join, you would need lab-confirmed evidence that you carry these bacteria based on routine samples taken during usual care.
This study builds a “registry,” which is a secure list of people with rare diseases or suspected rare diseases in Switzerland. It helps researchers better understand these conditions over time and improve care.
This study creates a collection of blood and other samples from people with various infections. Researchers will use these samples to better understand infections and develop new ways to diagnose and treat them.
Hear when a new Multiresistant Bacterial Pathogens trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.